WebApr 4, 2024 · Paradigm Biopharmaceuticals ASX:PAR Stock Report Last Price AU$1.30 Market Cap AU$365.5m 7D -3.0% 1Y 15.6% Updated 23 Mar, 2024 Data Company … WebApr 13, 2024 · Today's Range $460.54 $477.75 50-Day Range $407.62 $530.09 52-Week Range $301.69 $541.39 Volume 299,029 shs Average Volume 503,772 shs Market Capitalization $22.40 billion P/E Ratio 52.39 Dividend Yield 0.84% Price Target $542.09 Profile Analyst Ratings Chart Competitors Dividend Earnings Financials Insider Trades …
Why the Paradigm (ASX:PAR) share price is lifting today - MSN
WebOver the past six months, its share price has outperformed the ASX All Ordinaries Index by +0.14%. As of the last closing price of AU$1.30, shares in Paradigm Biopharmaceuticals were trading-2.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia. WebApr 6, 2024 · PAR News, Analysis, Announcements & Results Paradigm Biopharmaceuticals Limited AFR Paradigm Biopharmaceuticals Limited Follow … federal credit unions in tennessee
EDIT Stock Forecast, Price & News (Editas Medicine) - MarketBeat
WebDec 9, 2024 · NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Paradigm ("the Company"), the zero fee, institutional liquidity network for derivative traders, today announced the closing of a $35M Series A funding... It has been an interesting year for Paradigm shares, treading lower for most of 2024 until recently shooting higher. The company’s share price reached a year-to-date high of $2.17 on 9 August before going into a trading … See more Investors are scrambling to offload Paradigm shares amid an impending share dilution from the company. According to its announcement, Paradigm advised it has … See more The monies raised from the capital raise will be used to fund a number of initiatives that include the following: 1. Paradigm’s phase 3 clinical program and new drug application (NDA)-related activities; 2. Business … See more decorated goose egg shells